Desmopressin in the treatment of nocturnal polyuria in the male

BJU International

Volumn 84, Issue 1, 1999, Pages 20-24

  Cannon, A ^a   Carter, P G ^b   McConnell, A A ^c   Abrams, P ^d  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^b ST RICHARD S HOSPITAL   (United Kingdom)

^c INVERCLYDE ROYAL HOSPITAL   (United Kingdom)

^d SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Desmopressin; Nocturia; Nocturnal polyuria

Indexed keywords

DESMOPRESSIN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FLU LIKE SYNDROME; FLUID RETENTION; HEADACHE; HUMAN; HYPONATREMIA; INTRANASAL DRUG ADMINISTRATION; LETHARGY; MALE; MICTURITION; NECK PAIN; NOCTURIA; POLYURIA; PRIORITY JOURNAL; THROAT DISEASE; URINE VOLUME;

AGED; AGED, 80 AND OVER; BODY WEIGHT; CROSS-OVER STUDIES; DEAMINO ARGININE VASOPRESSIN; HUMANS; MALE; MIDDLE AGED; PLACEBOS; POLYURIA; RENAL AGENTS; TIME FACTORS; URINE;

EID: 0032793117     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1999.00125.x     Document Type: Article

References (28)

1. 1 Chute CG, Panser LA, Girman CJ et al. The prevalence of prostatism: a population based survey of urinary symptoms. J Urol 1993; 150: 85-9
2. 2 Homma Y, Imajo C, Takahashi S, Kawabe K, Aso Y. Urinary symptoms in a normal elderly population. Scand J Urol Nephrol 1994; 157 (Suppl); 27-30
3. 3 Imai K, Okabe K, Kobayashi D. Voiding disturbance in elderly males examined by prostate mass screening, Gumma Urological Oncology Croup. Jap J Urol 1991; 82: 1790-9
4. 4 Brocklehurst JC, Fry J, Griffiths LL, Kalton G, Dysuria in old age. J Am Griatr Soc 1971; 19: 582-92
5. 5 Carter PG. The role of nocturnal polyuria in nocturnal urinary symptoms in the healthy elderly male. MD Thesis, University of Bristol, 1992.
6. 6 Wasson JH, Bruskewitz RC, Elinson J et al. on behalf of The Department of Veterans Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia. A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. J Urol 1993; 150: 1696-700
7. 7 Stewart RB, Moore MT, May FE, Marks RG, Hale WE. Nocturia: a risk factor for falls in the elderly. J Am Geriatr Soc 1992; 40: 1217-20
8. 8 Tuvemo T. DDAVP in childhood nocturnal enuresis. Acta Paediatr Scand 1978; 67: 753-5
9. 9 Birkasova M, Birkas O, Flynn MJ, Cort JH. Desmopressin in the management of nocturnal enuresis in children: a double-blind study. Paediatrics 1978; 62: 970-4
10. 10 Ramsden PD, Hindmarsh JR, Price DA, Yeats WK, Bowditch JDP. DDAVP for adult enuresis. Br J Urol 1982; 54: 256-8
11. 11 Hilton P, Stanton SL. The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. Br J Urol 1982; 54: 252-5
12. 12 Asplund R, Aberg H. Desmopressin in elderly women with increased nocturnal diuresis. A short term study. Br J Urol 1993; 72: 42-5
13. 13 Hilton P, Hertogs K, Stanton SL. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Neurosurg Psych 1983; 46: 854-5
14. 14 Eckford SD, Swami KS, Jackson SR, Abrams PH. Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis. Br J Urol 1994; 74: 733-5
15. 15 Valiquette G, Herbert J, Maede-D'Alisera P. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind crossover trial. Arch Neurol 1996; 53: 1270-5
16. 16 Suchowersky O, Furtado S, Rohs G. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease. Mov Disord 1995; 10: 337-40
17. 17 Mansson W, Swindin T, Gullberg B. Evaluation of a synthetic vasopressin analogue for treatment of nocturia in benign prostatic hyperplasia. Scand J Urol Nephrol 1980; 14: 139-41
18. 18 Obara K, Takahashi M, Sato S. The effect of desmopressin (DDAVP) in patients complaining of nocturia. Jap J Urol 1993; 84: 2131-6
19. 19 Malone-Lee JG, Wiseman P. The safety of DDAVP in treating nocturnal symptoms. International Continence Society 21st Annual Meeting. Hannover, 1993: 183
20. 20 Robson WL, Leung AK. Side effects and complications of treatment with desmopressin for enuresis. J Natl Med Assoc 1994; 86: 775-8
21. 21 Abrams PH, Farrar DJ, Turner-Warwick RT, Whiteside CG, Feneley RCL. The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol 1979; 121: 640-2
22. 22 Doll HA, Black NA, McPherson K, Flood AB, Williams GB, Smith JC. Mortality, morbidity and complications following transurethral resection of the prostate for BPH. J Urol 1992; 147: 1566-73
23. 23 Neal DE, Ramsden PD, Sharples L et al. Outcome of elective prostatectomy. Br Med J 1989; 299: 762-7
24. 24 Pressman MR, Figuera WG, Kendrick-Mohamed J, Greenspon LW, Peterson DD. Nocturia. A rarely recognised symptom of sleep apnea and other occult sleep disorders. Arch Intern Med 1996; 156: 545-50
25. 25 Mills JN. Diurnal rhythm in urine flow. J Physiol 1951; 113: 528-36
26. 26 Simpsom GE. Diurnal variations in the rale of urinary excretion for two hour intervals: Some associated factors. J Biol Chem 1924; 59: 107-22
27. 27 Lobban MC, Tredre BE. Perception of light and the maintenance of human renal diurnal rhythms. J Physiol 1967; 189: 32-3
28. 28 Guite HF, Bliss MR, Mainwaring-Burton RW, Thomas J, Drury P. Hypothesis: Posture is one of the determimants of the circadian rhythm of urine flow and electrolyte excretion in elderly female patients. Age Ageing 1988; 17: 241-8